(S (NP-SBJ (NP (JJ Chronic) (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (NN infection)) (PP (IN of) (NP (JJ myeloid) (NNS cells)))) (VP (VBZ disrupts) (NP (NP (DT the) (JJ autoregulatory) (NN control)) (PP (IN of) (NP (DT the) (NN (Rel NF-kappaB)) (NN pathway)))) (PP (IN via) (NP (VBN enhanced) (NN IkappaBalpha) (NN degradation)))) (. .))
(S (NP-SBJ (JJ Productive) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (NN infection)) (VP (VBZ causes) (NP (JJ sustained) (NN NF-kappaB) (JJ DNA-binding) (NN activity)) (PP (IN in) (NP (ADJP (RB chronically) (VBN infected)) (JJ monocytic) (NNS cells)))) (. .))
(S (NP-SBJ (DT A) (JJ direct) (JJ temporal) (NN correlation)) (VP (VBZ exists) (PP (IN between) (NP-COOD (NP (NN HIV) (NN infection)) (CC and) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NN NF-kappaB) (JJ DNA-binding) (NN activity))) (PP (IN in) (NP (JJ myelomonoblastic) (NN PLB-985) (NNS cells))))))) (. .))
(S (S (NP-SBJ (-NONE- *-52)) (VP (TO To) (VP (VB examine) (NP (NP (DT the) (JJ molecular) (NN basis)) (PP (IN of) (NP (NP (JJ constitutive) (NN NF-kappaB) (JJ DNA-binding) (NN activity)) (PP (IN in) (NP HIV1 (JJ -infected) (NNS cells))))))))) (, ,) (NP-SBJ-52 (PRP we)) (VP (VBD analyzed) (NP (NP-COOD (NP (NP (DT the) (NP-COOD (NP (NN phosphorylation)) (CC and) (NP (NN turnover)))) (PP (IN of) (NP (NN IkappaBalpha) (NN protein)))) (, ,) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT the) (JJ double-stranded) (NP (NP (JJ RNA-dependent) (NN protein) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN PKR)) (-RRB- -RRB-)))))) (CC and) (NP (NP (DT the) (JJ intracellular) (NNS levels)) (PP (IN of) (NP (NN NF-kappaB) (NNS subunits))))) (PP (IN in) (NP (DT the) (NP-COOD (NP (NN PLB-985)) (CC and) (NP (NN U937))) (JJ myeloid) (NN cell) (NNS models))))) (. .))
(S (NP-SBJ (NN HIV-1) (NN infection)) (VP (VBD resulted) (PP (IN in) (NP (NP (ADJP-COOD (ADJP (JJ constitutive)) (, ,) (ADJP (JJ low-level))) (NN expression)) (PP (IN of) (NP (NN type) (CD 1) (NP (NP (NN interferon)) (PRN (-LRB- -LRB-) (NP (NN IFN)) (-RRB- -RRB-))))) (PP (IN at) (NP (DT the) (NN mRNA) (NN level)))))) (. .))
(S (NP-SBJ-53 (JJ Constitutive) (NN PKR) (NN activity)) (VP (VBD was) (ADVP (RB also)) (VP (VBN detected) (NP (-NONE- *-53)) (PP (IN in) (NP (JJ HIV-1-infected) (NNS cells))) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (JJ low-level) (NN IFN) (NN production))))) (, ,) (SBAR (IN since) (S (NP-SBJ (NP (DT the) (NN addition)) (PP (IN of) (NP (JJ (beta anti-IFN-alpha)) (NN antibody))) (PP (TO to) (NP (DT the) (NNS cells)))) (VP (VBD decreased) (NP (NN PKR) (NN expression))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (NP (DT the) (NN analysis)) (PP (IN of) (NP (NN IkappaBalpha) (NN turnover)))) (VP (VBD demonstrated) (NP (NP (DT an) (VBN increased) (NN degradation)) (PP (IN of) (NP (NN IkappaBalpha))) (PP (IN in) (NP (JJ HIV-1-infected) (NNS cells))) (SBAR (WHNP-54 (WDT that)) (S (NP-SBJ (-NONE- *T*-54)) (VP (MD may) (VP (VB account) (PP (IN for) (NP (DT the) (JJ constitutive) (NN DNA) (NN binding) (NN activity))))))))) (. .))
(S-COOD (S (NP-SBJ-COOD-55 (NP (NP (DT A) (JJ dramatic) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ intracellular) (NNS levels)) (PP (IN of) (NP (NN NF-kappaB) (NNS subunits) (NP-COOD (NP (NN c-Rel)) (CC and) (NP (NN NF-kappaB2) (NN p100)))))))) (CC and) (NP (NP (DT a) (JJ moderate) (NN increase)) (PP (IN in) (NP-COOD (NP (NN NF-kappaB2) (NN p52)) (CC and) (NP (NN RelA-LRB-p65-RRB-)))))) (VP (VBD were) (VP (VBN detected) (NP (-NONE- *-55)) (PP (IN in) (NP (JJ HIV-1-infected) (NNS cells)))))) (, ,) (IN whereas) (S (NP-SBJ-56 (NN NF-kappaB1) (NN (p50 p105)) (NNS levels)) (VP (VBD were) (RB not) (VP (VBN altered) (NP (-NONE- *-56)) (PP (JJ relative) (TO to) (NP (NP (DT the) (NNS levels)) (PP (IN in) (NP (JJ uninfected) (NNS cells)))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (NN HIV-1) (NN infection)) (PP (IN of) (NP (JJ myeloid) (NNS cells)))) (VP (VBZ induces) (NP (NP-COOD (NP (NN IFN) (NN production)) (CC and) (NP (NN PKR) (NN activity))) (, ,) (SBAR (WHNP-57 (WDT which)) (S (PP (IN in) (NP (NN turn))) (NP-SBJ (-NONE- *T*-57)) (VP (VBP contribute) (PP (TO to) (NP-COOD (NP (VBN enhanced) (NN IkappaBalpha) (NN phosphorylation)) (CC and) (NP (JJ subsequent) (NN degradation)))))))))))) (. .))
(S (NP-SBJ (NP (JJ Nuclear) (NN translocation)) (PP (IN of) (NP (NN NF-kappaB) (NNS subunits)))) (VP (MD may) (ADVP (RB ultimately)) (VP (VB increase) (NP (NP (DT the) (JJ intracellular) (NN pool)) (PP (IN of) (NP (NN (IkappaBalpha NF-kappaB))))) (PP (IN by) (NP (DT an) (JJ autoregulatory) (NN mechanism))))) (. .))
(S (NP-SBJ-COOD (NP (NP (VBN Enhanced) (NN turnover)) (PP (IN of) (NP (NN IkappaBalpha)))) (CC and) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN (Rel NF-kappaB)) (NNS proteins))))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (ADJP (RB chronically) (JJ activated)) (NN state)) (PP (IN of) (NP (JJ HIV-1-infected) (NNS cells))))))) (. .))
